5.0
29. Juni 2012
Mitarbeiter (anonym)
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great friendly leadership. Excellent mentoring program.
Kontras
Pharma industry experiencing heavy consolidation due to inability of pharmaceutical companies to develop new blockbuster drugs largely due to the fact that most simplistic biological and biochemical drug mechanisms have been developed.